Rhythm Pharmaceuticals (RYTM) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RYTM is expected to report earnings to rise 47.27% to -81 cents per share on November 05

Rhythm Pharmaceuticals RYTM Stock Earnings Reports

Q3'24

Est.

$-0.81

Q2'24

Beat

by $0.16

Q1'24

Est.

$-2.35

Q4'23

Est.

$-0.70

Q3'23

Est.

$-0.76

The last earnings report on August 06 showed earnings per share of -55 cents, beating the estimate of -70 cents. With 167.92K shares outstanding, the current market capitalization sits at 3.14B.

View a ticker or compare two or three

Compare

RYTM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RYTM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RYTM (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of peptide therapeutics for metabolic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

222 Berkeley Street

Phone

+1 857 264-4280

Employees

226

Web

http://www.rhythmtx.com